MAVENCLAD

cladribine · EMD Serono, Inc.

Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for MAVENCLAD, covering 2015-10-20 to 2026-03-12. Get the full timeline:

Most recent: Clinical Trial Update: Consolidation Therapy With Cladribine in Relapsing Multiple Sclerosis Patients